PTEN and breast carcinoma: In this study, paired tumor and normal tissues from a cohort of 313 Chinese breast cancer patients were screened for ATK1, PIK3CA, PTEN and TP53 mutations using microfluidic PCR-based target enrichment and NGS technology.